People · Operator
Named in public records as an officer, director or promoter · active 2011–2024 · Retailing, Pharmaceuticals, Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Coravin, Inc. | — | Retailing | Series B | $68.8M | $25.7M | 2011 |
| Astrocyte Pharmaceuticals Inc. | — | Pharmaceuticals | Series A | $12.8M | $31.6M | 2020 |
| Xeno Biosciences Inc. | — | Biotechnology | Series A | $12.1M | $16.4M | 2021 |
| First Light Biosciences Inc. | — | Biotechnology | Seed | $7.7M | $133.2M | 2016 |
| Magnendo Corp. | — | Other Technology | Seed | $2.3M | $11.8M | 2024 |
Jeffrey Arnold at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey Arnold on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Joshua Makower | 1 | 10 |
| Jeff Arnold | 1 | 5 |
| David Shapiro | 1 | 4 |
| Michelle Stacy | 1 | 3 |
| Josh Makower | 1 | 3 |
| William Moffitt | 1 | 3 |
| Stan Rose | 1 | 3 |
| Jeffrey L. Ives | 1 | 3 |
| Tripp Peake | 1 | 2 |
| Jeffrey Ives | 1 | 2 |
| Michael Koeris | 1 | 2 |
| Greg Lambrecht | 1 | 2 |
| Thierry Bernard | 1 | 2 |
| Donald Straus | 1 | 2 |
| Richard Ganz | 1 | 1 |
| Michael Lytton | 1 | 1 |
| Salvatore Salamone | 1 | 1 |
| Mark Dockser | 1 | 1 |
| Yoonho Kim | 1 | 1 |
| Xuanhe Zhao | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.